Understand the role of bacteria and the microbiome in your study, project or program, with unprecedented completeness, accuracy and detail. The microbiome is a key variable, and no longer needs to be an unknown or uncontroled one.

Intus Bio’s Titan-1 platform powers complete ‘sample to answer’ services at scale for pharma, biotech and research partners, giving them revolutionary new ways to stratify patients, de-risk trials and improve patient safety through the unique production of high-resolution microbiome data at scale.

The platform can also deliver response prediction, biomarker identification, and unprecedented insights into the role of the bacterial microbiome for any study or trial – regardless of the nature or target.

The microbiome is a key variable which can now be incorporated at any stage, in any study or trial.